EcoDrugPlus

Acetylcholinesterase

Ensembl ID : ENSCCRG00000072608
Gene Symbol: ACHE
1 Cross references
231 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSCCRG00000077302
Gene Symbol: ACHE
1 Cross references
231 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSCCRG00000069373
Gene Symbol: ACVR2BA
1 Cross references
191 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSCCRG00000045243
Gene Symbol: ACVR2BA
1 Cross references
191 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSCCRG00000071109
Gene Symbol: ADORA1B
1 Cross references
198 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSCCRG00000057125
Gene Symbol: ADORA1B
1 Cross references
197 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSCCRG00000019281
Gene Symbol: ADORA2AA
1 Cross references
184 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSCCRG00000063856
Gene Symbol: ADORA2B
1 Cross references
197 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSCCRG00000011895
Gene Symbol: ADA
1 Cross references
215 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSCCRG00000011844
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSCCRG00000072930
Gene Symbol: ADRA1AA
1 Cross references
199 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSCCRG00000033198
Gene Symbol: ADRA1AA
1 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).